In this paper, we propose a mathematical model with five nonlinear differential equations describing the interactions between HIV, CD4 + T cells, and the adaptive immune response represented by cytotoxic T lymphocytes (CTL) cells and the antibodies. In addition, the lag between the time when the virus enters a cell and when the cell becomes infected is modeled by a distributed time delay. The global stability of the steady states od the model is determined by using the direct Lyapunov functional method.
Introduction
Human immunodeficiency virus (HIV) is a lentivirus that causes acquired immunodeficiency syndrome (AIDS). Nowadays, HIV infection is an important and serious worldwide cause of mortality. Recently, many mathematical models (see [8, 11, 5, 4, 6, 2, 10, 1] ) have been developed in order to understand the dynamics of HIV infection.
In this paper, we consider the following HIV infection model with adaptive immune response and distributed time delay governed by nonlinear differential equations:
x(t) = λ − dx(t) − βx(t)v(t), y(t)
= β h 0 f (τ )e −
mτ x(t − τ )v(t − τ )dτ − ay(t) − py(t)z(t), v(t) = ky(t) − μv(t) − qv(t)w(t), w(t) = gv(t)w(t) − hw(t), z(t) = cy(t)z(t) − bz(t), (1) where x(t), y(t), v(t), w(t) and z(t) denote the concentration of uninfected cells, infected cells, free virus particles, antibody response and CTL response at time t, respectively.
The uninfected cells are produced at a constant λ, die a rate dx and become infected by free virus at a rate βxv. Infected cells are lost at a rate ay and are killed by the CTL response at a rate pyz. Free viruses are produced by infected cells at a rate ky, cleared at a rate uv and are neutralized by antibodies at a rate qvw. Antibodies develop in response to free virus at a rate gvw and decay at a rate hw. CTL cells expand in response to viral antigen derived from infected cells at a rate cyz and decay in the absence of antigenic stimulation at a rate bz. Here, we assume that the uninfected cells are contacted by the virus particles at time t − τ becomes infected cells at time t, where τ is a random variable with a probability distribution f (τ ) over the interval [0, h] and h is limit superior of this delay. This probability distribution is assumed to be a positive and integrable function on [0, h], and satisfying h 0 f (τ )dτ = 1. The term e −mτ is the probability of surviving from time t − τ to time t, where m is the death rate for infected but not yet virus-producing cells
The novelty of our study is that it incorporates both humoral and cellular responses and investigates the impact of the distributed delay on the dynamical behavior of HIV infection.
The rest of the paper is organized as follows. Section 2 deals with positivity and boundedness of solutions. The equilibria of the model and five threshold parameters are given in Section 3. In Section 4, we discuss the global stability of the equilibria. The paper ends with a conclusion in Section 5.
Positivity and boudedness of solutions
In this section, we establish the positivity and boundedness of solutions of system (1) .
be the Banach space of continuous functions mapping the interval [−h, 0] into R 5 with the topology of uniform convergence. By the fundamental theory of functional differential equations [3] , it is easy to show that there exists a unique solution (x(t), y(t), v(t), w(t), z(t)) of system (1) with initial data (x 0 , y 0 , v 0 , w 0 , z 0 ) ∈ C. For biological reasons, we assume that the initial data for system (1) satisfy:
Proposition 2.1 All solutions of system (1) subject to condition (2) remains nonnegative and bounded for all t ∈ [0, +∞).
Proof. From (1), we have
From (3), (6) and (7), we have
, it is easy to show, from (4)and (5), that y(t) ≥ 0 and v(t) ≥ 0 for all t ∈ [0, h]. This method can be repeated to deduce non-negativity of y, and v on the interval [h, 2h] and then on successive intervals [nh, (n+1)h], n ≥ 2, to include all positive times. Next, we show the boundedness of solutions. Let
We havė
Hence,Ṫ (t) ≤ λ − δT (t) with δ = min{d,
, T (0)}. and T is bounded. Therefore, all variables of (1) are bounded. This completes the proof.
Equilibria and threshold parameters
In order to establish the global dynamics of system (1), we derive five threshold parameters, that are:
where A = 
As in [9] , we remark that 
If
D z 0 D w 0 H w 0 < 1 or D w 0 D z 0 < 1, E 2 does not exists. In addition, E 4 = E 3 if D z 0 D w 0 H w 0 = 1, and E 4 = E 2 if D w 0 D z 0 = 1.
Global Stability
In this section, we study the global stability of five equilibria
Therefore, we have the following main result. 
is globally asymptotically stable.
Proof. For each E i , we consider the following Lyapunov functional
where m i = a kA when i ∈ {0, 1, 3}, and
when i ∈ {2, 4}. First, we prove (i). For i = 0, we get
.
, we have that
, we have v = 0 and y = 0. By LaSalle's invariance principle, we have E 0 is globally asymptotically stable.
For i = 0 we have
Using the fact that λ = dx i + βx i v i , we have
Using the relation: ln(
= 0. Then x = x 1 , and v 1 y = vy 1 . And from first equation of (1) we have v = v 1 , and thereafter y = y 1 . And from the other equation of (1) we have w = 0 and z = 0. By LaSalle's invariance principle [7] , we have E 1 is globally asymptotically stable.
If i = 2, we get
Since F (s) ≥ 0, ∀s > 0 and
If dL 2 dt = 0. Then x = x 2 and v 2 y = vy 2 . And from first equation of (1) we have v = v 2 and from the other equation of (1) 
Since F (s) ≥ 0, ∀s > 0 and 
Conclusion
In this work, we have proposed a mathematical model with distrusted time delay and both humoral and cellular immune responses. The global stability of equilibria is completely determined by five thresholds parameters. More precisely, we have proved that when R 0 ≤ 1, the disease-free equilibrium E 0 is globally asymptotically stable. When R 0 > 1, four endemic equilibria appear that are: the immune-free equilibrium E 1 which is globally asymptotically stable if H (8)). In addition, this R 0 is independent of the immune parameters that are b, c, p, g, h and q, which means that the adaptive immune response is unable to eliminate the virus, but it can reduce the concentration of viral load and increase the concentration of healthy CD4 + cells, which can see by comparing the components of the viral load and those of the concentration of CD4 + before and after the activation of both CTL and antibody immune response.
